Results of a single masked, randomized two-year controlled clinical trial
The real value of this study, however, lies in the follow-up findings after cessation of the outdoor intervention.
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
The authors suggest the need for more rigorous clinical trials.
Combined interventions for myopia will potentially influence the standard of care.
Existing evidence has failed to convince doctors to uniformly embrace treatments for myopic progression control.
Does planning extra time outdoors during the school day help?
Results of a recent survey spanning eight years.